Nifty

:

23155.35

Sensex

:

76404.99

130.70 (0.57%)
566.63 (0.75%)

Login

Nifty
Sensex

:
:

23155.35
76404.99

130.70 (0.57%)
566.63 (0.75%)

Par Drugs And Chemicals Ltd.

Chemicals

Rating :

N/A

BSE: Not Listed | NSE: PAR

Watchlist

NSE BSE

196.34

22-Jan-2025

Open
High
Low
Previous Close

194.00
200.01
194.00
197.09

Volume
Traded Value (lacs)
52 Week High
52 Week Low

53415
105.93
348.45
180.50

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

241.59
13.28
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

222.81
N/A
2.51

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.14
11.36
8.41

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.81
19.31
7.03

PAT CAGR (%)

10 Years
5 Years
3 Years

32.19
24.95
16.33

P:E (Median)

8 Years
5 Years
3 Years

-
19.03
19.89

P:BV (Average)

8 Years
5 Years
3 Years

-
2.89
3.23

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
9.96
11.09

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 34.66 25.89 33.87% 22.61 22.93 -1.40% 22.82 24.49 -6.82% 24.00 22.93 4.67%
Expenses 23.25 18.52 25.54% 18.37 18.80 -2.29% 16.73 19.11 -12.45% 18.77 19.70 -4.72%
EBITDA 11.41 7.36 55.03% 4.23 4.13 2.42% 6.09 5.38 13.20% 5.23 3.23 61.92%
EBIDTM 32.92% 28.44% 18.73% 18.02% 26.70% 21.97% 21.78% 14.08%
Other Income 1.02 0.05 1,940.00% 0.07 0.01 600.00% -0.05 0.03 - 0.23 0.04 475.00%
Interest 0.03 0.03 0.00% 0.02 0.02 0.00% 0.05 0.03 66.67% 0.02 0.03 -33.33%
Depreciation 0.91 0.85 7.06% 0.90 0.83 8.43% 0.89 0.85 4.71% 0.87 0.74 17.57%
PBT 11.49 6.54 75.69% 3.38 3.30 2.42% 5.11 4.54 12.56% 4.57 2.50 82.80%
Tax 2.89 1.65 75.15% 0.85 0.83 2.41% 1.39 1.09 27.52% 1.15 0.63 82.54%
PAT 8.60 4.89 75.87% 2.53 2.47 2.43% 3.72 3.45 7.83% 3.42 1.87 82.89%
PATM 24.81% 18.89% 11.20% 10.76% 16.29% 14.07% 14.25% 8.14%
EPS 6.99 3.98 75.63% 2.06 2.01 2.49% 3.02 2.80 7.86% 2.78 1.52 82.89%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 104.09 95.64 95.75 75.07 60.75 55.85 46.32 42.38 48.77 33.26 33.25 Net Sales Growth 8.16% -0.11% 27.55% 23.57% 8.77% 20.57% 9.30% -13.10% 46.63% 0.03% Cost Of Goods Sold 34.67 33.79 40.33 28.82 21.88 23.65 19.22 17.93 21.07 12.86 13.00 Gross Profit 69.42 61.85 55.42 46.25 38.87 32.19 27.10 24.45 27.70 20.40 20.25 GP Margin 66.70% 64.67% 57.88% 61.61% 63.98% 57.64% 58.51% 57.69% 56.80% 61.33% 60.90% Total Expenditure 77.12 72.82 77.54 58.82 44.74 46.41 38.12 34.35 40.30 26.08 25.78 Power & Fuel Cost - 16.40 17.83 13.49 9.82 10.70 8.90 6.94 8.45 5.11 6.40 % Of Sales - 17.15% 18.62% 17.97% 16.16% 19.16% 19.21% 16.38% 17.33% 15.36% 19.25% Employee Cost - 3.83 3.34 2.72 2.69 2.82 2.21 2.01 1.84 1.79 1.26 % Of Sales - 4.00% 3.49% 3.62% 4.43% 5.05% 4.77% 4.74% 3.77% 5.38% 3.79% Manufacturing Exp. - 5.70 4.81 4.29 3.71 3.34 2.67 2.79 5.62 4.63 1.65 % Of Sales - 5.96% 5.02% 5.71% 6.11% 5.98% 5.76% 6.58% 11.52% 13.92% 4.96% General & Admin Exp. - 3.19 2.68 2.73 2.33 2.52 2.51 2.01 2.16 1.22 1.01 % Of Sales - 3.34% 2.80% 3.64% 3.84% 4.51% 5.42% 4.74% 4.43% 3.67% 3.04% Selling & Distn. Exp. - 8.50 8.34 6.61 4.30 3.18 2.58 2.66 1.11 0.46 1.83 % Of Sales - 8.89% 8.71% 8.81% 7.08% 5.69% 5.57% 6.28% 2.28% 1.38% 5.50% Miscellaneous Exp. - 1.40 0.22 0.16 0.01 0.18 0.02 0.01 0.05 0.01 1.83 % Of Sales - 1.46% 0.23% 0.21% 0.02% 0.32% 0.04% 0.02% 0.10% 0.03% 1.92% EBITDA 26.96 22.82 18.21 16.25 16.01 9.44 8.20 8.03 8.47 7.18 7.47 EBITDA Margin 25.90% 23.86% 19.02% 21.65% 26.35% 16.90% 17.70% 18.95% 17.37% 21.59% 22.47% Other Income 1.27 0.24 0.24 0.18 0.19 0.10 0.09 0.04 0.04 0.04 0.04 Interest 0.12 0.11 0.13 0.45 0.64 0.79 1.96 2.33 2.50 3.57 3.95 Depreciation 3.57 3.44 3.23 3.28 2.82 2.76 3.04 3.14 2.82 2.65 2.33 PBT 24.55 19.52 15.08 12.70 12.74 5.99 3.29 2.60 3.18 1.01 1.22 Tax 6.28 5.02 3.75 3.49 3.11 1.23 0.78 1.07 1.34 0.59 0.34 Tax Rate 25.58% 25.72% 24.87% 27.48% 21.11% 20.53% 23.71% 41.15% 42.14% 58.42% 27.87% PAT 18.27 14.50 11.33 9.21 11.61 4.76 2.51 1.52 1.85 0.42 0.89 PAT before Minority Interest 18.27 14.50 11.33 9.21 11.61 4.76 2.51 1.52 1.85 0.42 0.89 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 17.55% 15.16% 11.83% 12.27% 19.11% 8.52% 5.42% 3.59% 3.79% 1.26% 2.68% PAT Growth 44.09% 27.98% 23.02% -20.67% 143.91% 89.64% 65.13% -17.84% 340.48% -52.81% EPS 14.85 11.79 9.21 7.49 9.44 3.87 2.04 1.24 1.50 0.34 0.72

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 14
Shareholder's Funds 85.63 71.24 59.88 52.21 40.61 29.03 20.96 19.20 17.36 16.16 Share Capital 12.30 12.30 12.30 6.15 6.15 4.48 8.45 8.45 8.45 8.45 Total Reserves 73.33 58.93 47.57 46.06 34.46 24.55 12.51 10.75 8.91 7.71 Non-Current Liabilities 3.54 3.64 3.96 8.19 8.66 9.78 15.92 17.25 18.69 26.94 Secured Loans 0.00 0.00 0.00 0.59 0.61 2.23 2.97 5.17 8.50 18.35 Unsecured Loans 0.00 0.00 0.00 3.80 4.01 3.80 9.62 9.13 7.98 7.06 Long Term Provisions 0.00 0.14 0.41 0.39 0.39 0.33 0.00 0.24 0.19 0.00 Current Liabilities 12.44 13.99 14.86 15.98 10.84 12.46 17.00 19.59 21.99 18.29 Trade Payables 5.36 8.09 10.66 6.72 6.20 4.93 5.26 7.78 6.44 4.62 Other Current Liabilities 1.94 1.98 0.80 2.47 2.69 2.33 6.13 4.50 5.23 5.36 Short Term Borrowings 0.00 0.00 0.00 3.25 0.00 4.32 5.08 6.53 10.00 7.84 Short Term Provisions 5.14 3.92 3.40 3.55 1.95 0.87 0.53 0.79 0.32 0.47 Total Liabilities 101.61 88.87 78.70 76.38 60.11 51.27 53.88 56.04 58.04 61.39 Net Block 41.31 38.45 34.10 29.91 34.40 36.34 39.04 41.53 42.61 47.06 Gross Block 73.84 67.57 60.02 52.54 57.32 56.71 56.36 55.73 54.13 53.61 Accumulated Depreciation 32.53 29.12 25.91 22.63 22.92 20.37 17.33 14.19 11.53 6.55 Non Current Assets 41.99 39.43 35.13 35.20 35.90 37.08 39.79 42.46 43.42 47.69 Capital Work in Progress 0.03 0.25 0.25 4.52 0.74 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.01 0.01 0.01 0.01 0.06 0.06 0.06 0.06 0.06 0.00 Long Term Loans & Adv. 0.64 0.73 0.76 0.76 0.71 0.69 0.70 0.66 0.60 0.63 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.21 0.15 0.00 Current Assets 59.62 49.44 43.56 41.19 24.22 14.18 14.10 13.58 14.61 13.70 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 4.18 5.38 4.71 3.00 2.92 4.29 4.07 3.99 5.58 3.49 Sundry Debtors 13.71 16.97 18.47 12.45 12.37 8.52 8.72 8.11 7.38 7.76 Cash & Bank 36.65 22.24 16.21 21.16 7.38 0.03 0.06 0.02 0.93 0.73 Other Current Assets 5.08 0.04 0.12 0.19 1.55 1.34 1.24 1.47 0.73 1.72 Short Term Loans & Adv. 5.04 4.80 4.06 4.38 1.49 1.30 1.20 1.44 0.70 0.48 Net Current Assets 47.18 35.45 28.71 25.21 13.37 1.73 -2.91 -6.01 -7.37 -4.59 Total Assets 101.61 88.87 78.69 76.39 60.12 51.26 53.89 56.04 58.03 61.39

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 14
Cash From Operating Activity 20.25 13.38 7.62 12.09 7.69 3.36 4.65 9.39 6.53 5.30 PBT 19.52 15.08 12.70 14.73 5.99 3.29 2.60 3.27 1.01 1.21 Adjustment 3.09 3.02 3.46 1.29 3.41 4.31 5.03 5.22 6.11 6.04 Changes in Working Capital 2.00 -0.46 -5.43 -0.34 -0.85 -3.54 -2.60 1.65 -0.55 -1.66 Cash after chg. in Working capital 24.61 17.64 10.74 15.68 8.54 4.07 5.03 10.13 6.57 5.59 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -4.36 -4.26 -3.12 -3.59 -0.85 -0.71 -0.38 -0.74 -0.04 -0.29 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -5.84 -7.34 -3.02 0.05 -1.46 -0.25 -0.60 -1.70 -0.17 -6.17 Net Fixed Assets -6.05 -7.55 -3.21 1.00 -1.35 -0.35 -0.63 -1.60 -0.52 -6.18 Net Investments 0.00 0.00 0.00 0.05 0.00 0.00 0.00 0.00 -0.06 0.00 Others 0.21 0.21 0.19 -1.00 -0.11 0.10 0.03 -0.10 0.41 0.01 Cash from Financing Activity 0.00 0.00 -9.55 1.65 1.11 -3.14 -4.00 -8.60 -5.46 1.58 Net Cash Inflow / Outflow 14.41 6.04 -4.96 13.78 7.35 -0.03 0.05 -0.91 0.90 0.71 Opening Cash & Equivalents 22.24 16.21 21.16 7.38 0.03 0.06 0.02 0.93 0.03 0.03 Closing Cash & Equivalent 36.65 22.24 16.21 21.16 7.38 0.03 0.06 0.02 0.93 0.73

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 69.59 57.90 48.66 42.44 33.01 32.40 28.17 24.91 21.49 20.88 ROA 15.23% 13.53% 11.88% 17.01% 8.56% 4.78% 2.77% 3.24% 0.72% 1.48% ROE 18.49% 17.29% 16.44% 25.02% 13.68% 11.35% 10.63% 14.75% 3.69% 8.18% ROCE 25.02% 23.20% 21.85% 28.68% 15.56% 12.41% 11.19% 12.34% 9.36% 9.92% Fixed Asset Turnover 1.52 1.70 1.51 1.26 1.11 0.94 0.87 0.89 0.62 0.62 Receivable days 52.21 59.70 66.50 65.58 59.99 59.42 63.27 57.97 81.71 83.87 Inventory Days 16.26 17.00 16.58 15.63 20.71 28.81 30.27 35.81 52.42 40.95 Payable days 72.63 84.87 110.04 107.79 85.91 45.83 64.81 60.43 83.26 77.46 Cash Conversion Cycle -4.16 -8.16 -26.96 -26.58 -5.21 42.39 28.74 33.34 50.86 47.36 Total Debt/Equity 0.00 0.00 0.00 0.16 0.15 0.40 1.10 1.29 1.77 1.92 Interest Cover 183.23 114.21 28.97 23.93 8.55 2.68 2.11 2.27 1.28 1.31

Top Investors:

jainam broking limited

vardhilal shivrambhai thakkar

Annual Reports:

News Update:

Par Drugs & Chem. - Quarterly Results
22nd Oct 2024, 12:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback